Literature DB >> 24867851

Riboflavin and migraine: the bridge over troubled mitochondria.

Bruno Colombo1, Lorenzo Saraceno, Giancarlo Comi.   

Abstract

Brain energy metabolism has been found to be disturbed in migraine. A mitochondrial defect may reduce the threshold for migraine attacks both increasing neuronal excitability and leading migrainous brain to a hyper-responsiveness to triggering stimuli. Riboflavin, a major co-factor in oxidative metabolism, may overcome this impairment. RCT studies in adult confirmed that riboflavin is safe and probably effective in migraine prophylaxis, based on level B evidence. Improving brain energy metabolism may reduce the susceptibility to migraine when brain energy demand increases due to both physiological and biopsychological factors.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24867851     DOI： 10.1007/s10072-014-1755-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  24 in total

Review 1.  Prophylactic migraine therapy: mechanisms and evidence.

Authors:  Nabih M Ramadan
Journal:  Curr Pain Headache Rep       Date:  2004-04

Review 2.  Nutraceuticals and headache: the biological basis.

Authors:  Frederick R Taylor
Journal:  Headache       Date:  2011-03       Impact factor: 5.887

3.  Canadian Headache Society guideline for migraine prophylaxis.

Authors:  Tamara Pringsheim; W Jeptha Davenport; Gordon Mackie; Irene Worthington; Michel Aubé; Suzanne N Christie; Jonathan Gladstone; Werner J Becker
Journal:  Can J Neurol Sci       Date:  2012-03       Impact factor: 2.104

4.  Riboflavin-responsive complex I deficiency.

Authors:  H R Scholte; H F Busch; H D Bakker; J M Bogaard; I E Luyt-Houwen; L P Kuyt
Journal:  Biochim Biophys Acta       Date:  1995-05-24

5.  A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.

Authors:  Morris Maizels; Andrew Blumenfeld; Raoul Burchette
Journal:  Headache       Date:  2004-10       Impact factor: 5.887

6.  Abnormal platelet mitochondrial function in patients affected by migraine with and without aura.

Authors:  S Sangiorgi; M Mochi; R Riva; P Cortelli; L Monari; G Pierangeli; P Montagna
Journal:  Cephalalgia       Date:  1994-02       Impact factor: 6.292

Review 7.  Is the cerebral cortex hyperexcitable or hyperresponsive in migraine?

Authors:  G Coppola; F Pierelli; J Schoenen
Journal:  Cephalalgia       Date:  2007-12       Impact factor: 6.292

8.  Riboflavin prophylaxis in pediatric and adolescent migraine.

Authors:  Maria Condò; Annio Posar; Annalisa Arbizzani; Antonia Parmeggiani
Journal:  J Headache Pain       Date:  2009-08-01       Impact factor: 7.277

Review 9.  Magnetic resonance spectroscopy studies in migraine.

Authors:  P Montagna; P Cortelli; B Barbiroli
Journal:  Cephalalgia       Date:  1994-06       Impact factor: 6.292

10.  Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs.

Authors:  C Di Lorenzo; F Pierelli; G Coppola; G S Grieco; C Rengo; M Ciccolella; D Magis; M Bolla; C Casali; F M Santorelli; J Schoenen
Journal:  Neurology       Date:  2009-05-05       Impact factor: 9.910
View more
  12 in total

1.  Is there an association between NC_012920.1: m.8277T> C mitochondrial variation the mt-NC7 locus, and migraine with aura?

Authors:  S Güler; H Gürkan; S Demir
Journal:  Hippokratia       Date:  2020 Apr-Jun       Impact factor: 0.471

2.  Riboflavin and vitamin E increase brain calcium and antioxidants, and microsomal calcium-ATP-ase values in rat headache models induced by glyceryl trinitrate.

Authors:  Ayşe Bütün; Mustafa Nazıroğlu; Serpil Demirci; Ömer Çelik; Abdulhadi Cihangir Uğuz
Journal:  J Membr Biol       Date:  2014-11-26       Impact factor: 1.843

3.  Cyclic vomiting syndrome versus inborn errors of metabolism: A review with clinical recommendations.

Authors:  Amy A Gelfand; Renata C Gallagher
Journal:  Headache       Date:  2015-12-18       Impact factor: 5.887

4.  Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model.

Authors:  Wei He; Ting Long; Qi Pan; Shanshan Zhang; Yixin Zhang; Dunke Zhang; Guangcheng Qin; Lixue Chen; Jiying Zhou
Journal:  J Neuroinflammation       Date:  2019-04-10       Impact factor: 8.322

Review 5.  The Use of Antioxidants in the Treatment of Migraine.

Authors:  Marta Goschorska; Izabela Gutowska; Irena Baranowska-Bosiacka; Katarzyna Barczak; Dariusz Chlubek
Journal:  Antioxidants (Basel)       Date:  2020-01-28

6.  Riboflavin in cyclic vomiting syndrome: efficacy in three children.

Authors:  Anastasia Martinez-Esteve Melnikova; Michela G Schäppi; Christian Korff
Journal:  Eur J Pediatr       Date:  2015-07-31       Impact factor: 3.183

7.  Valproate Attenuates Nitroglycerin-Induced Trigeminovascular Activation by Preserving Mitochondrial Function in a Rat Model of Migraine.

Authors:  Ruxian Li; Yushuang Liu; Nan Chen; Yitong Zhang; Ge Song; Zhongling Zhang
Journal:  Med Sci Monit       Date:  2016-09-12

8.  A splice variant in the ACSL5 gene relates migraine with fatty acid activation in mitochondria.

Authors:  Fuencisla Matesanz; María Fedetz; Cristina Barrionuevo; Mohamad Karaky; Antonio Catalá-Rabasa; Victor Potenciano; Raquel Bello-Morales; Jose-Antonio López-Guerrero; Antonio Alcina
Journal:  Eur J Hum Genet       Date:  2016-05-18       Impact factor: 4.246

9.  Normal/high-fat milk consumption is associated with higher lean body and muscle mass in Japanese women aged between 40 and 60 years: a cross-sectional study.

Authors:  Yuri Sukenobe; Masakazu Terauchi; Asuka Hirose; Miho Hirano; Mihoko Akiyoshi; Kiyoko Kato; Naoyuki Miyasaka
Journal:  BMC Womens Health       Date:  2018-02-02       Impact factor: 2.809

10.  Proteasome inhibitors modulate anticancer and anti-proliferative properties via NF-kB signaling, and ubiquitin-proteasome pathways in cancer cell lines of different organs.

Authors:  Asaf A Qureshi; Eleanor G Zuvanich; Dilshad A Khan; Shahida Mushtaq; Neerupma Silswal; Nilofer Qureshi
Journal:  Lipids Health Dis       Date:  2018-04-02       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.